Yahoo Web Search

    • Could These Be the Next 2 Biotech Buyouts?

      Could These Be the Next 2 Biotech Buyouts?

      The Motley Fool· 23 hours ago

      Agios is a midsize cancer drug developer that's already earned Food and Drug Administration (FDA) approvals for two new and novel cancer therapies, and the company still owns one of them outright ...